From USFDA
Strides Shasun announced that it has received approval from the USFDA for Memantine Hydrochloride Tablets USP, 5 mg and 10 mg. The product will be manufactured at the Company's flagship facility at Bangalore and marketed by Strides Pharma Inc in the US market. The product will be launched immediately.Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)